Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fischer 344 rats

Cheng Feng Yang, Jin Liu, Shanthi Wasser, Han Ming Shen, Carolyn Eng Looi Tan, Choon Nam Ong

Research output: Contribution to journalArticlepeer-review

48 Scopus citations


Aflatoxin B1 (AFB1), a potent hepatocarcinogen, enhances ROS formation and causes oxidative DNA damage, which may play a role in its carcinogenicity. We have demonstrated recently that ebselen, an organic selenium compound, protects against the cytotoxicity of AFB1 through its antioxidant capability. The present study was designed to investigate the effect of ebselen on AFB1-induced hepatocarcinogenesis in an animal model. Fischer 344 rats were first treated with either deionized water or ebselen (5 mg/kg, 5 days/week) via gavage for 4 weeks, then given AFB1 (0.4 mg/kg, gavage, once a week) or AFB1 plus ebselen (5 mg/kg, 5 days/week) for another 24 weeks. The results showed that the hepatocarcinogenicity of AFB1 in rats was significantly reduced by ebselen treatment as indicated by a decrease in: (i) serum γ-glutamyl transpeptidase activity; (ii) expression of mRNAs of liver α-fetoprotein and the placental form of glutathione S-transferase (GST-P); and (iii) the area and mean density of staining of liver GST-P foci. Ebselen treatment significantly reduced the formation of hepatic AFB1-DNA adducts and 8-hydroxydeoxyguanosine caused by AFB1 exposure. These findings suggest that ebselen can inhibit the carcinogenicity of AFB1. In addition to the reduction of AFB1-DNA adduct formation, the protective effect of ebselen against AFB1-induced oxidative DNA damage may also, at least in part, contribute to its anticarcinogenic property.

Original languageEnglish
Pages (from-to)2237-2243
Number of pages7
Issue number12
StatePublished - 2000

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fischer 344 rats'. Together they form a unique fingerprint.

Cite this